Jan/Feb 2005
|
‘High Dosage’ Opioid Management
The criteria for optimal opioid dosing for a specific patient must be
clinically-adequate pain control and functional improvement while avoiding cognitive
impairment and respiratory depression.
by J.S. Hochman MD
|
‘Opiophobia’ Past and Present
The one drug class that has the optimum profile to manage severe, unremitting,
intractable pain — opioids — is often shunned.
by Bruce R. Moldovan, JD
Pain Management Pitfalls
Psychological research on intense provider-client interactions yields insight into the
doctor-chronic pain patient relationship.
by Ron Lechnyr, PhD, DSW, and Terri A. Lechnyr, MSW, LCSW
Musculo-Skeletal Diagnostic Ultrasound Imaging
This evolving, first-line imaging test for soft tissue lesions can provide superior
diagnostic accuracy by visualizing internal soft tissue architecture and associated
pathologies.
by Tiziano Marovino, DPT, FAAPM
Diagnosing and Managing Interstitial Cystitis
New research suggests interstitial cystitis (IC), a painful bladder disorder, is quite
prevalent in the general population.
by Matt T. Rosenberg, MD; Matthew A. Hazzard, BA; and Charles W. Butrick, MD
Selection Criteria for Intrathecal Opioid Therapy
A survey of the “science” behind exclusionary psychological assessment finds
that supporting empirical data is virtually non-existent.
by Michael E. Schatman, PhD
Intractable Pain Centers’ Treatment Approach
Correctly identifying and certifying intractable pain patients legitimizes palliative
treatments that may be required to alleviate the debilitating pain and suffering of these
individuals.
by Thomas J. Purtzer, MD
Editor's Memo
Primary Care Physicians and Schedule II, Long-Acting Opioids
by Forest A. Tennant, MD, DrPH
Viewpoint
Ignoring Risk-Benefit Analyses: The Cox II Tragedy
by Forest A. Tennant, MD, DrPH
|